Bioequivalence Study Protocol Optimizer
Optimize bioequivalence study protocols with statistical power and regulatory compliance
What You Can Do
You can design optimized bioequivalence study protocols from the ground up, determining appropriate sampling times, statistical power calculations, and sample size justifications. The skill guides you through regulatory compliance verification against FDA 320.1, EMA CPMP, and ICH M9 guidelines, while helping you make critical decisions about study design (crossover vs. parallel), fed/fasted conditions, washout duration, and PK parameter selection with documented outlier handling procedures.
Features
calculates required subject numbers based on CV, effect size, and regulatory requirements
guides selection of primary endpoints (Cmax, AUC) with outlier detection and handling procedures
verifies protocol alignment with FDA, EMA, and ICH guidelines before submission
compares crossover vs. parallel designs, period duration, and washout recommendations
structured logic for determining study conditions based on drug properties and formulation
evidence-based guidance for collection windows to capture PK profiles accurately
data integrity, QA documentation, and contingency procedures for protocol deviations
pre-formatted sections for statistical analysis plans and protocol summaries
Example Output
Example 1: Sample Size Calculation Output
- Study Design: 2-way crossover, randomized, fasting
- Assumptions: CV = 22%, Target Power = 90%, Bioequivalence margin 80-125%
- Required sample size: 28 subjects (14 per sequence)
- Justification: Based on pilot data and regulatory precedent for modified-release formulations
Example 2: PK Parameter Selection & Compliance Check
- Primary endpoints: Cmax, AUC0-t, AUC0-∞
- Outlier handling: Studentized residuals >3.0 flagged for review; washout verification required
- FDA Compliance: ✓ Aligned with 21 CFR 320.1(c)
- EMA Compliance: ✓ Meets CPMP/EWP/QWP guideline
Example 3: Study Design Recommendation
- Formulation type: Extended-release tablet
- Recommended design: 2-way crossover, fasting + fed states (separate studies)
- Washout period: 7 days (based on half-life = 2.5 hours)
- Sampling windows: Predose, 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24, 36, 48 hours
What's Included
- SKILL.md instruction file: systematic protocol optimization workflow and compliance framework
- Statistical Power Analysis Template: sample size calculator with CV inputs and power curves
- PK Parameter Selection Checklist: guideline-compliant endpoint definitions with outlier procedures
- Regulatory Compliance Matrix: FDA, EMA, and ICH requirement cross-reference with decision trees
- Study Design Decision Framework: fed/fasted, crossover/parallel, washout duration recommendations
- Protocol Safeguards Checklist: data integrity, QA documentation, and deviation contingencies
Who It's For
- Bioanalytical Scientists — designing BE studies and optimizing protocol parameters before bioanalytical method validation
- Regulatory Affairs Specialists — verifying protocol compliance with FDA, EMA, and ICH guidelines for submission
- Clinical Research Coordinators — translating protocol requirements into study operations and sampling timelines
- Pharmaceutical R&D Project Managers — evaluating study feasibility, risk, and timelines during protocol development
- Contract Research Organization (CRO) Scientists — standardizing BE protocol design across multiple client submissions
Best For
- Designing bioequivalence study protocols for immediate-release and modified-release formulations
- Conducting statistical power analysis and sample size justification with regulatory documentation
- Determining optimal PK sampling times based on drug pharmacokinetics and formulation properties
- Verifying regulatory compliance across FDA, EMA, and ICH guidelines before protocol finalization
- Creating fed/fasted study decision frameworks and crossover design optimization for complex formulations
You might also like
You can systematically design computational experiments that produce statistically valid, methodologically sound, and reproducible results. This skill guides you through hypothesis formulation, pipeline architecture, rigorous validation protocols, and comprehensive documentation—ensuring your computational research meets publication standards and survives peer review scrutiny.
by zagmoai
This skill helps you design scientifically rigorous and regulatory-compliant bioequivalence study protocols in a fraction of the time. Claude analyzes FDA and ICH guidance documents to extract all applicable requirements, calculates statistically powered sample sizes for your specific formulation and study design, and generates protocol drafts structured for regulatory review. You'll identify compliance gaps, risk mitigate protocol weaknesses, and accelerate CRO handoff with submission-ready documentation.
by kody-w
You can rapidly diagnose why therapeutic proteins are degrading by mapping observed failure modes to underlying mechanisms, then recommend ranked excipient and buffer strategies to stabilize them. The skill interprets analytical data (SEC, DLS, DSF, HPLC) to pinpoint degradation pathways, predicts how manufacturing processes impact stability, and prioritizes experiments by expected impact—eliminating guesswork and accelerating formulation development.
by zagmoai